Current management of patients with invasive cervical carcinoma

Clinical Obstetrics and Gynecology

Volumn 44, Issue 3, 2001, Pages 531-537

  Grigsby, Perry W ^a   Herzog, Thomas J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA;

BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; EVIDENCE BASED MEDICINE; HUMAN; HYSTERECTOMY; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; NEOPLASM STAGING; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0034886210     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200109000-00008     Document Type: Conference Paper

References (16)

1. Class II versus Class III radical hysterectomy in Stage IB-IIA cervical cancer: A prospective randomized study 1,2
2. Type II radical hysterectomy: Evaluating its role in cervical cancer
3. New approaches in the surgical management of early stage cervical cancer
4. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer
5. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study
6. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
7. Adjuvant hysterectomy after radiation therapy reduces detection of local recurrence in "bulky" stage IB cervical cancer without improving survival: Results of a prospective randomized GOG trial
8. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study
9. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
10. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
11. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinoma: Ten-year treatment results of RTOG 79-20
12. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
13. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study
14. Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: Radiotherapy or surgery 1988-1995
15. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes
16. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: Results of a randomized gynecology ontology group study